Okuno, K., Xu, C., Pascual Sabater, S., Tokunaga, M., Han, H., Fillat, C., . . . Goel, A. (2022). Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma.
Citación estilo ChicagoOkuno, Keisuke, Caiming Xu, Silvia Pascual Sabater, Masanori Tokunaga, Haiyong Han, Cristina Fillat, Yusuke Kinugasa, y Ajay Goel. Berberine Overcomes Gemcitabine-Associated Chemoresistance Through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. 2022.
Cita MLAOkuno, Keisuke, et al. Berberine Overcomes Gemcitabine-Associated Chemoresistance Through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. 2022.
Precaución: Estas citas no son 100% exactas.